This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Bruce E. Jarrell, MD; S. Szentpetery, MD; Gerardo Mendez-Picon, MD; H. M. Lee, MD; Lazar J. Greenfield, MD

Arch Surg. 1981;116(7):930-932.

Abstract
Renal transplant patients in whom deep vein thrombosis and pulmonary embolism (PE) develop usually respond to heparin sodium treatment. A small percentage of transplant patients will require vena caval filter placement to prevent recurrent PE, and this report details our experience with two patients. In one patient there was a contraindication to heparin, and in the other, a massive recurrent PE. Greenfield filters were inserted transvenously in these patients and found to be well tolerated. There was no evidence of renal compromise, recurrent PE, or other complications. Follow-up venograms confirmed the presence of patent vena cavas with properly positioned filters. Autopsy studies subsequently performed confirmed the clinical assessment of each patient's course, and neither patient died of recurrent embolism.

(Arch Surg 1981;116:930-932)

Author Affiliations
From the Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond.

Footnotes
Accepted for publication Nov 13, 1980.

Reprint requests to Department of Surgery, Medical College of Virginia, Box 645, Virginia Commonwealth University, Richmond, VA 23298 (Dr Greenfield).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Greenfield Vena Caval Filter Experience: Late Results in 156 Patients
Greenfield et al.
Arch Surg 1981;116:1451-1456.
ABSTRACT